1. 方法論と範囲
1.1. 調査方法
1.2. 調査目的と調査範囲
2. 定義と概要
3. エグゼクティブ・サマリー
3.1. フォーム別スニペット
3.2. ソース別スニペット
3.3. アプリケーション別スニペット
3.4. 地域別スニペット
4. ダイナミクス
4.1. 影響要因
4.1.1. 推進要因
4.1.1.1. 変形性関節症の有病率の上昇
4.1.1.2. スポーツ栄養への関心の高まり
4.1.2. 阻害要因
4.1.2.1. ビーガンと倫理的懸念
4.1.3. 機会
4.1.4. 影響分析
5. 産業分析
5.1. ポーターのファイブフォース分析
5.2. サプライチェーン分析
5.3. 価格分析
5.4. 規制分析
5.5. ロシア・ウクライナ戦争の影響分析
5.6. DMI意見
6. 形式別
6.1. はじめに
6.1.1. 市場規模分析および前年比成長率分析（%）, 形態別
6.1.2. 市場魅力度指数（形態別
6.2. ドライ*市場
6.2.1. 序論
6.2.2. 市場規模分析と前年比成長率分析(%)
6.3. 液体
7. ソース別
7.1. 紹介
7.1.1. ソース別市場規模分析および前年比成長率分析（%）.
7.1.2. 市場魅力度指数, 供給源別
7.2. 牛
7.2.1. はじめに
7.2.2. 市場規模分析と前年比成長率分析(%)
7.3. 豚肉
7.4. 家禽
7.5. その他
8. 用途別
8.1. 導入
8.1.1. 用途別市場規模分析および前年比成長率分析(%)
8.1.2. 市場魅力度指数、用途別
8.2. 食品・飲料*市場
8.2.1. 序論
8.2.2. 市場規模分析と前年比成長率分析(%)
8.3. ヘルスケア
8.4. 化粧品
8.5. その他
9. 地域別
9.1. はじめに
9.1.1. 地域別市場規模分析および前年比成長率分析(%)
9.1.2. 市場魅力度指数、地域別
9.2. 北米
9.2.1. 序論
9.2.2. 主な地域別ダイナミクス
9.2.3. 市場規模分析および前年比成長率分析（%）, 形態別
9.2.4. 市場規模分析および前年比成長率分析（%）：供給源別
9.2.5. 市場規模分析および前年比成長率分析（%）, 用途別
9.2.6. 市場規模分析および前年比成長率分析（%）, 国別
9.2.6.1. 米国
9.2.6.2. カナダ
9.2.6.3. メキシコ
9.3. ヨーロッパ
9.3.1. はじめに
9.3.2. 主な地域別動向
9.3.3. 市場規模分析および前年比成長率分析（%）, 形態別
9.3.4. 市場規模分析および前年比成長率分析（%）：供給源別
9.3.5. 市場規模分析および前年比成長率分析（%）, 用途別
9.3.6. 市場規模分析および前年比成長率分析（%）, 国別
9.3.6.1. ドイツ
9.3.6.2. イギリス
9.3.6.3. フランス
9.3.6.4. イタリア
9.3.6.5. スペイン
9.3.6.6. その他のヨーロッパ
9.4. 南米
9.4.1. はじめに
9.4.2. 地域別主要市場
9.4.3. 市場規模分析および前年比成長率分析（%）, 形態別
9.4.4. 市場規模分析および前年比成長率分析（%）：供給源別
9.4.5. 市場規模分析および前年比成長率分析（%）, 用途別
9.4.6. 市場規模分析および前年比成長率分析（%）, 国別
9.4.6.1. ブラジル
9.4.6.2. アルゼンチン
9.4.6.3. その他の南米諸国
9.5. アジア太平洋
9.5.1. はじめに
9.5.2. 主な地域別ダイナミクス
9.5.3. 市場規模分析および前年比成長率分析（%）, 形態別
9.5.4. 市場規模分析および前年比成長率分析（%）：供給源別
9.5.5. 市場規模分析および前年比成長率分析（%）, 用途別
9.5.6. 市場規模分析および前年比成長率分析（%）, 国別
9.5.6.1. 中国
9.5.6.2. インド
9.5.6.3. 日本
9.5.6.4. オーストラリア
9.5.6.5. その他のアジア太平洋地域
9.6. 中東・アフリカ
9.6.1. 序論
9.6.2. 主な地域別ダイナミクス
9.6.3. 市場規模分析および前年比成長率分析（%）, 形態別
9.6.4. 市場規模分析および前年比成長率分析（%）：供給源別
9.6.5. 市場規模分析および前年比成長率分析（%）, 用途別
10. 競争環境
10.1. 競争シナリオ
10.2. 市場ポジショニング／シェア分析
10.3. M&A分析
11. 企業プロフィール
11.1. Ashland Inc.*
11.1.1. 会社概要
11.1.2. 製品ポートフォリオと内容
11.1.3. 財務概要
11.1.4. 主な展開
11.2. Athos Collagen Private Limited
11.3. Chondrex, Inc.
11.4. Advanced BioMatrix
11.5. Rousselot
11.6. Takara Bio Inc.
11.7. SouthernBiotech
11.8. REPROCELL Inc.
11.9. KOKEN CO., LTD.
11.10. JINBO BIO-PHARMACEUTICAL CORPORATION LIMITED（※リストは全てではありません。）
12. 付録
12.1. 会社概要とサービス
12.2. お問い合わせ
The Global Type II Collagen Market reached US$ 214.48 million in 2023 and is expected to reach US$ 302.92 million by 2031, growing at a CAGR of 4.41% during the forecast period 2024-2031.
As the aging population grows globally, there is an increasing awareness of joint health and mobility issues. Type II collagen, known for its ability to support cartilage and joint function, is seeing heightened demand. The trend drives global type II collagen market expansion, particularly among elderly consumers and individuals with active lifestyles who prioritize joint health.
According to the World Health Organization, countries face significant challenges in preparing their health and social systems for the rapid demographic shift toward an aging population. By 2050, it is projected that 80% of older adults will reside in low- and middle-income countries and the pace of population aging is accelerating at an unprecedented rate.
In 2020, for the first time, the number of people aged 60 years and older surpassed the number of children under the age of five. Furthermore, between 2015 and 2050, the proportion of the global population over 60 will nearly double, increasing from 12% to 22%. This demographic change requires urgent action to adapt healthcare and social support systems to the needs of older individuals.
Market Dynamics
Rising Prevalence of Osteoarthritis
As osteoarthritis becomes more common, especially among the aging population, the demand for effective treatments and joint health supplements significantly increases. Type II collagen, known for its role in supporting joint health and reducing inflammation, is increasingly being incorporated into dietary supplements, functional foods and pharmaceuticals to address the growing needs of those affected by this condition.
For instance, according to the Osteoarthritis (OA) Action Alliance, the prevalence of OA varies by age, gender and ethnicity. Age-wise, 43% of individuals with OA are 65 or older and 88% are 45 or older. The highest annual incidence of knee OA occurs between the ages of 55 and 64, although more than half of those with symptomatic knee OA are under 65. Gender differences show that 62% of individuals with OA are women. While OA is more common in men under 45, it becomes more prevalent in women after that age. In terms of ethnicity, 78% of those with OA are non-Hispanic whites.
Growing Interest in Sports Nutrition
The growing interest in sports nutrition is expected to drive the global type II collagen market significantly. As athletes and fitness enthusiasts increasingly focus on joint health, recovery and performance enhancement, type II collagen is gaining attention for its potential benefits in supporting joint integrity, reducing inflammation and promoting cartilage repair, driving the market growth.
The market is witnessing a rise in demand for collagen-based supplements, especially from individuals engaged in high-impact sports. These consumers seek products that can help maintain their joint health and prevent injury, contributing to the expansion of the type II collagen segment within the broader sports nutrition market. This trend is further supported by the growing awareness of collagen's role in improving mobility and flexibility, making it a key ingredient in the market for sports supplements and functional foods.
According to Bulk CEO, the rising popularity of strength training has propelled the direct-to-consumer (DTC) nutrition brand to a record-breaking performance, with revenues surging by 30% to EUR 123.1 million in 2023. Strong customer retention and record-high new customer acquisition were key drivers behind this growth. Bulk added nearly 800,000 new customers last year and sold over nine million products, with clear whey protein emerging as the fastest-growing line and the value essentials range performing well amid the cost of living crisis.
Creatine products remained popular among customers focused on muscle mass building, while collagen and magnesium products saw increased demand as recovery solutions. Bulk’s impressive revenues boosted adjusted EBITDA to EUR 9.3 million, up from EUR 2.6 million in 2022 and pre-tax profits rose to EUR 6 million, compared to just EUR 66k the previous year, despite inflation-driven ingredient cost hikes.
Vegan and Ethical Concerns
As consumer demand shifts towards plant-based and cruelty-free products, a growing segment of the market is becoming increasingly wary of products derived from animal sources, such as type II collagen, which is typically sourced from chicken sternum or other animal tissues. This ethical stance, combined with the rising vegan population globally, may hinder the growth of the type II collagen market, as consumers seek alternative, plant-based solutions for joint health and skin care.
Moreover, the type II collagen market is also likely to face challenges as brands navigate the ethical debates around animal welfare and sustainability. The production methods for animal-derived collagen are often scrutinized for their environmental impact, which can further dampen demand in markets where sustainability and ethical sourcing are high priorities, restraining market growth.
Market Segment Analysis
The global type II collagen market is segmented based on form, source, application and region.
Rising Consumer Demand for Type II Collagen Skin Health Products
The cosmetics segment holds the largest share of the global type II collagen market due to a combination of rising consumer demand for skin health products and the increasing awareness of collagen's role in enhancing skin elasticity, hydration and overall appearance. As consumers become more focused on maintaining a youthful appearance, there is a surge in the popularity of anti-aging products, with type II collagen becoming a key ingredient.
The growing demand for anti-aging and skin-rejuvenating solutions is driving the cosmetics market forward with type II collagen’s proven benefits. The cosmetics industry is continually evolving with innovative product formats such as collagen-infused masks, lotions and ingestible beauty supplements. For instance, on January 24, 2023, Geltor expanded into the hair care market with the launch of NuColl, a vegan collagen produced through fermentation.
Market Geographical Share
Increasing Prevalence of Joint Disorders in North America
North America is expected to dominate the global type II collagen market. The primary driver is the region's rapidly aging population, which is leading to an increasing prevalence of joint disorders such as osteoarthritis. This is creating significant demand for joint health supplements, where type II collagen is widely used for its potential to support cartilage and improve joint function.
Growing consumer awareness about the benefits of collagen supplements, driven by extensive marketing efforts and strong distribution channels, is contributing to market expansion in North America. The region also benefits from a highly developed healthcare infrastructure and a robust dietary supplement market, allowing for easier access to collagen-based products. These trends, along with a focus on product innovation and new formulations, are helping North America maintain its leading position in the global type II collagen market.
Market Competitive Landscape
The major global players in the market include Ashland Inc., Athos Collagen Private Limited, Chondrex, Inc., Advanced BioMatrix, Rousselot, Takara Bio Inc., SouthernBiotech, REPROCELL Inc., KOKEN CO., LTD. and JINBO BIO-PHARMACEUTICAL CORPORATION LIMITED.
Russia-Ukraine War Impact Analysis
The ongoing Russia-Ukraine war has significantly affected the global type II collagen market, influencing supply chains and consumer behavior. The conflict has disrupted agricultural activities and trade routes in Eastern Europe, leading to shortages and increased prices of key ingredients sourced from the region. This disruption in supply chains has resulted in heightened production costs for manufacturers in the type II collagen market, prompting some companies to pass these costs on to consumers.
The war has contributed to broader economic instability, affecting consumer spending patterns and priorities. In times of uncertainty, consumers may reduce discretionary spending on supplements, including type II collagen products. This could slow market growth as demand fluctuates, especially in regions heavily reliant on imports from affected countries.
By Form
Dry
Liquid
By Source
Bovine
Porcine
Poultry
Others
By Application
Food and beverage
Healthcare
Cosmetics
Others
By Region
North America
US
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Rest of Europe
South America
Brazil
Argentina
Rest of South America
Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
Middle East and Africa
Key Developments
On November 4, 2023, Lee Pharma, a Hyderabad-based pharmaceutical company, received marketing authorization to launch its Bio-Cartilage SmoothWalk tablets in the United Arab Emirates. This milestone marks a significant achievement for the company, as Bio-Cartilage SmoothWalk becomes the first Indian nutraceutical product to be licensed in the UAE.
On March 3, 2022, ByHealth, a leading vitamin and dietary supplements company in China, introduced a new collagen product under its Highflex joint health brand. This product features Collavant n2, a native (undenatured) type II collagen ingredient from Bioiberica (Barcelona), which has been clinically proven to alleviate knee discomfort and improve joint function.
On April 20, 2021, Lonza announced the expansion of its UC-II undenatured collagen ingredient line with the launch of a new supplement made from certified organic collagen and verified by the Non-GMO Project. The new UC-II undenatured type II collagen aims to solve this by offering a consumer-friendly, once-daily dose, providing a more convenient option for those in the organic joint-health market.
Why Purchase the Report?
To visualize the global type II collagen market segmentation based on form, source, application and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel spreadsheet containing a comprehensive dataset of the type-ii-collagen-market, covering all levels of segmentation.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as Excel consisting of key products of all the major players.
The global type II collagen market report would provide approximately 62 tables, 53 figures and 202 pages.
Target Audience 2024
Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies
1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Form
3.2. Snippet by Source
3.3. Snippet by Application
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Prevalence of Osteoarthritis
4.1.1.2. Growing Interest in Sports Nutrition
4.1.2. Restraints
4.1.2.1. Vegan and Ethical Concerns
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion
6. By Form
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
6.1.2. Market Attractiveness Index, By Form
6.2. Dry*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Liquid
7. By Source
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
7.1.2. Market Attractiveness Index, By Source
7.2. Bovine*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Porcine
7.4. Poultry
7.5. Others
8. By Application
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Food and beverage*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Healthcare
8.4. Cosmetics
8.5. Others
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.2.6.1. US
9.2.6.2. Canada
9.2.6.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.3.6.1. Germany
9.3.6.2. UK
9.3.6.3. France
9.3.6.4. Italy
9.3.6.5. Spain
9.3.6.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.4.6.1. Brazil
9.4.6.2. Argentina
9.4.6.3. Rest of South America
9.5. Asia-Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.5.6.1. China
9.5.6.2. India
9.5.6.3. Japan
9.5.6.4. Australia
9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10. Competitive Landscape
10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis
11. Company Profiles
11.1. Ashland Inc.*
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Financial Overview
11.1.4. Key Developments
11.2. Athos Collagen Private Limited
11.3. Chondrex, Inc.
11.4. Advanced BioMatrix
11.5. Rousselot
11.6. Takara Bio Inc.
11.7. SouthernBiotech
11.8. REPROCELL Inc.
11.9. KOKEN CO., LTD.
11.10. JINBO BIO-PHARMACEUTICAL CORPORATION LIMITED (*LIST NOT EXHAUSTIVE)
12. Appendix
12.1. About Us and Services
12.2. Contact Us
❖ 世界のII型コラーゲン市場に関するよくある質問(FAQ) ❖
・II型コラーゲンの世界市場規模は？
→DataM Intelligence社は2023年のII型コラーゲンの世界市場規模を2億1,448万米ドルと推定しています。
・II型コラーゲンの世界市場予測は？
→DataM Intelligence社は2031年のII型コラーゲンの世界市場規模を3億292万米ドルと予測しています。
・II型コラーゲン市場の成長率は？
→DataM Intelligence社はII型コラーゲンの世界市場が2024年～2031年に年平均4.4%成長すると予測しています。
・世界のII型コラーゲン市場における主要企業は？
→DataM Intelligence社は「Ashland Inc., Athos Collagen Private Limited, Chondrex, Inc., Advanced BioMatrix, Rousselot, Takara Bio Inc., SouthernBiotech, REPROCELL Inc., KOKEN CO., LTD. and JINBO BIO-PHARMACEUTICAL CORPORATION LIMITED.など ...」をグローバルII型コラーゲン市場の主要企業として認識しています。
※上記FAQの市場規模、市場予測、成長率、主要企業に関する情報は本レポートの概要を作成した時点での情報であり、納品レポートの情報と少し異なる場合があります。
